Study of A-101 for the Treatment of Seborrheic Keratosis
Status:
Completed
Trial end date:
2015-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and dose-response of 2 concentrations of
A-101 versus a vehicle control in the treatment of seborrheic keratosis.